IP Library Assignment 068276/0306
Patent Assignment
Reel/Frame 068276/0306

Assignment of Assignor's Interest

Recorded: 2024-08-14 Pages: 7
Assignor
Assignee
ADC THERAPEUTICS (UK) LTD
4TH FLOOR READING BRIDGE HOUSE, GEORGE STREET, READING, BERKSHIRE, RG1 8LS, UNITED KINGDOM
Covered Property (1)
Combination Therapy with an Anti-Axl Antibody-Pbd Conjugate and Nanocups
Application: 18/837,459 →
Publication: US 2025/0152725
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 14, 2024
From: ADC THERAPEUTICS (UK) LTD
To: ADC THERAPEUTICS SA
Reel/Frame 068276/0575 →
Assignment of Assignor's Interest Aug 14, 2024
From: ADC THERAPEUTICS SA
To: MEDIMMUNE LIMITED
Reel/Frame 068276/0967 →
Assignment of Assignor's Interest Aug 14, 2024
From: WUERTHNER, JENS
To: ADC THERAPEUTICS SA
Reel/Frame 068276/0973 →
Assignment of Assignor's Interest Aug 14, 2024
From: ADC THERAPEUTICS SA
To: MEDIMMUNE LIMITED
Reel/Frame 068277/0035 →
Assignment of Assignor's Interest Aug 14, 2024
From: ROWE, CLIFF; MASIERO, MASSIMO; COVIELLO, CHRISTIAN
To: OXSONICS LIMITED
Reel/Frame 068595/0078 →
Patent Security Agreement Dec 9, 2024
From: ADC THERAPEUTICS SA
To: BLUE OWL OPPORTUNISTIC MASTER FUND I, L.P. (FORMERLY KNOWN AS OWL ROCK OPPORTUNISTIC MASTER FUND I, L.P.)
Reel/Frame 069560/0540 →